Umakoshi Noriyuki, Matsui Yusuke, Tomita Koji, Uka Mayu, Kawabata Takahiro, Iguchi Toshihiro, Hiraki Takao
Department of Radiology, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama 700-8558, Japan.
Department of Radiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kitaku, Okayama 700-8558, Japan.
Cancers (Basel). 2023 Jul 18;15(14):3665. doi: 10.3390/cancers15143665.
The most common sites of extrahepatic metastases from hepatocellular carcinoma (HCC) are the lungs, intra-abdominal lymph nodes, bones, and adrenal glands, in that order. Although systemic therapies are a common treatment for patients with extrahepatic metastases, local ablative therapies for the extrahepatic metastatic lesions can be performed in selected patients. In this article, the literature on image-guided thermal ablation for metastasis to each organ was reviewed to summarize the current evidence. Radiofrequency ablation was the most commonly evaluated technique, and microwave ablation, cryoablation, and percutaneous ethanol injection were also utilized. The local control rate of thermal ablation therapy was relatively favorable, at approximately 70-90% in various organs. The survival outcomes varied among the studies, and several studies reported that the absence of viable intrahepatic lesions was associated with improved survival rates. Since only retrospective data from relatively small studies has been available thus far, more robust studies with prospective designs and larger cohorts are desired to prove the usefulness of thermal ablation for extrahepatic metastases from HCC.
肝细胞癌(HCC)肝外转移最常见的部位依次为肺、腹腔内淋巴结、骨和肾上腺。尽管全身治疗是肝外转移患者的常用治疗方法,但对于部分患者,可对肝外转移病灶进行局部消融治疗。本文回顾了各器官转移灶的影像引导热消融相关文献,以总结当前证据。射频消融是评估最多的技术,微波消融、冷冻消融和经皮乙醇注射也有应用。热消融治疗的局部控制率相对较好,在各器官中约为70% - 90%。不同研究的生存结果有所不同,一些研究报告称肝内无存活病灶与生存率提高相关。由于目前仅有相对小型研究的回顾性数据,因此需要更有力的前瞻性设计和更大队列研究来证明热消融对HCC肝外转移的有效性。